Johnson & Johnson Reports Q4 and Full-Year 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Johnson & Johnson (JNJ) shares gain as Q4 earnings and guidance beats
January 24, 2023 6:52 AM ESTShares of Johnson & Johnson (NYSE: JNJ) rose in pre-open trading Tuesday after the pharmaceutical giant reported better-than-expected fourth-quarter earnings results and earnings guidance.
Fourth quarter sales declined 4.4% to $23.7 billion on unfavorable foreign exchange and reduced COVID-19 vaccine sales. This was below the Wall... More
Johnson & Johnson (JNJ) Tops Q4 EPS by 11c, Revenues Misses; Guides EPS Above Views
January 24, 2023 6:26 AM ESTJohnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.35, $0.11 better than the analyst estimate of $2.24. Revenue for the quarter came in at $23.7 billion versus the consensus estimate of $23.9 billion.
GUIDANCE:
Johnson & Johnson sees FY2023 EPS of $10.50, versus the consensus of... More
